Author

Tony Sang

Institution: Kenya Medical Research Institute

Observed institution: Kenya Medical Research Institute

OpenAlex ID: A5110679232

Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial

2021 · Martina Oneko, Laura C. Steinhardt, et al. · Nature Medicine · 95

Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial

2022 · Aaron M Samuels, Daniel Ansong, et al. · The Lancet Infectious Diseases · 70

Impact of Community-Based Mass Testing and Treatment on Malaria Infection Prevalence in a High-Transmission Area of Western Kenya: A Cluster Randomized Controlled Trial

2020 · Aaron M Samuels, Nobert Awino Odero, et al. · Clinical Infectious Diseases · 47

Safety, Tolerability, and Immunogenicity of Plasmodium falciparum Sporozoite Vaccine Administered by Direct Venous Inoculation to Infants and Young Children: Findings From an Age De-escalation, Dose-Escalation, Double-blind, Randomized Controlled Study in Western Kenya

2019 · Laura C Steinhardt, Thomas L Richie, et al. · Clinical Infectious Diseases · 37

Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: development of study site infrastructure and lessons learned

2019 · Norbert Awino Odero, Aaron M. Samuels, et al. · Malaria Journal · 13

Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: study design and methodology for a cluster randomized controlled trial

2017 · Aaron M. Samuels, Nobert Awino, et al. · Malaria Journal · 8

Could Less Be More? Accounting for Fractional-Dose Regimens and Different Number of Vaccine Doses When Measuring the Impact of the RTS,S/AS01E Malaria Vaccine

2024 · Nelli Westercamp, Lawrence Osei-Tutu, et al. · The Journal of Infectious Diseases · 4

Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trial

2025 · Lawrence Osei-Tutu, Simon K Kariuki, et al. · The Lancet Global Health · 3

Mass testing and treatment on malaria in an area of western Kenya

2020 · Aaron M Samuels, Nobert Awino Odero, et al. · Clinical Infectious Diseases

Works count: 9

Citation count: 277

H-index: 6

I10-index: 5